- Andrew Hourani, CEO Groove Health
The Novo Nordisk Innovation Partnering Program, in collaboration with MATTER, is part of the relationship that we hope to develop with the healthcare innovation community. We aim to explore, design and co-develop digital health solutions that help people living with diabetes achieve better health. We invite professional and collegiate innovators to participate in the 2018-2019 Innovation Challenge.
Submissions are accepted SEPTEMBER 25, 2018 through OCTOBER 29, 2018 at 11:59 pm CST. Novo Nordisk will evaluate submissions on a rolling basis. Enter now for your best chance to participate!Apply Here
Read the stories of Katie and Jose real people living with diabetes, to better understand their unmet needs. Download their health data to develop smart solutions with actionable insights.
Digital tools, health IT and software technologies, healthcare service solutions, diagnostic technologies and devices. We invite solutions that could potentially be integrated with our device systems (like device, app or cloud platforms).
Individuals and teams from across the innovation ecosystem — from existing startups, university researchers, students, incubators or accelerators, as well as other industry innovators. The challenge is open to solutions of all stages, from early stage ideas and university-based concepts to marketed solutions.
Living with diabetes is a burden, both for newer patients — who may feel overwhelmed by the high degree of self-care needed — and for experienced patients — who may, understandably, grow tired of managing their condition and become less engaged over time. We believe that by seamlessly measuring, tracking and sharing health data, we can enable a better dialogue between patients and their physicians or caregivers and create a more holistic picture of health, helping make self-care easier for those living with diabetes and, ultimately, leading to clinically actionable insights and better health outcomes.
We are seeking novel ideas and bold solutions, developed using data from our marketed pen injectors, that deliver holistic and integrated care to improve and optimize diabetes management. In partnership with the healthcare innovation community, we are interested in exploring, designing and co-developing solutions that will enhance patient experience, empower patients to improve their self-care to achieve a sense of normalcy, and enable smarter, more efficient management of diabetes.